B

Baroness Sherlock (Lab)

Speaking in the House of Lords on 28 October 2026

Debate

Pneumoconiosis etc. (Workers’ Compensation) (Payment of Claims) (Amendment) (No. 2) Regulations 2026

Contribution

My Lords, I am very grateful to the noble Lord, Lord Palmer, and the noble Baroness, Lady Stedman-Scott, for those responses, and I thank them for their clear support for these changes. I had every confidence that the Committee would appreciate the alignment of rates for dependants with those for sufferers. As the noble Lord, Lord Palmer, pointed out and as was helpful to hear in the discussion, these diseases are products of our industrial heritage. The people suffering from them just went to work. That was a very poignant way to put it: they had simply gone to work and done the right thing; then, from no fault of their own, they ended up suffering these terrible diseases decades later. The least we can do is to support people by giving them this compensation in the late years of their life. With these changes, that can carry on; sometimes these diseases progress horrifically quickly and the claims cannot be processed in time. At least now the sufferers will know that their dependants will get the money due to them. There were a couple of other questions. If the noble Baroness, Lady Stedman-Scott, does not mind, as she was asking for quite a lot of specific detail about projections, I will write to her on those because it would be too much to go through them now. There were two questions I want specifically to address. One was whether anyone will lose out. It is not possible to rule out that a small number of people may receive less than they otherwise would have, as a result of removing certain supplementary provisions. But the department expects the number affected to be very small. Taken together with the annual uprating and the wider package of reforms, the overall effect is expected to be positive for claimants and their dependants. At the moment, the gap between sufferers and dependants can be £7,000; it is that specific. If I have any more precise information about modelling, I will write to noble Lords. Both noble Lords raised clearance times and why people are waiting for longer processing times, both for claims and related documentation. I reassure the Committee that reducing processing times is a clear priority for my department. Journey times vary depending on the complexity of individual cases and, in some instances, additional checks are needed to make sure that the entitlement criteria are properly met. That can take longer, but it is important to get the decisions right. We are working hard to reduce backlogs and speed up claims, including by modernising processes that have been around since before the pandemic and expanding the use, where appropriate, of paper-based or video assessments for IIDB. For certain prescribed conditions, including diffuse mesothelioma and seven other specified conditions, disablement is automatically assessed at 100%, which means that a medical assessment may not be necessary. That would help ensure that those with the most serious conditions receive faster decisions. I reassure noble Lords that we are working hard on that. There is no doubt that there has been an increase in processing times for mesothelioma claims, but officials are working hard to address that and to make sure that customers receive their awards as quickly as possible. I want to reassure the Committee that the department fully understands the implication of that and the impact on families and is working through understanding the reasons for that. I think those are the main questions that were asked, but I will go through Hansard and if I have missed anything else, I will write to noble Lords. I thank noble Lords for their continued support for these schemes. The Government are committed to sharing the importance of them. I commend to the Committee the importance of these reforms, which align compensation payable to dependants with that payable to sufferers under both schemes, and the fact that they will also allow provision for payment to personal representatives. The schemes will continue to support people affected by some of the most serious occupational diseases and, where appropriate, their dependants. The reforms before the Committee were prompted by an independent legal review of the schemes, and they provide an opportunity to address a number of long-standing issues relating to their operation. Taken together, these changes will align awards for dependants and sufferers. They will provide greater clarity. I say to the noble Baroness, Lady Stedman-Scott, that I share her position and add my thanks to many charities who have worked in this area. As regards communications, we published a press notice on the reforms, endorsed by the Asbestos Victims Support Group Forum, to raise awareness of the changes, and we will always keep an eye out for ways to make sure people know what is there. As for an estimation of awards, I am reflecting further. The dependant rate increase is estimated to cost between £2 million and £6 million annually and the relevant date changes are expected to cost under £1 million. Both were funded through the 2025 spending review. On numbers, in 2025-26 there were 220 awards to dependants under the 1979 Act scheme, which is about 10% of the total caseload, with £2.5 million paid out. On the 2008 Act scheme there were around 70 awards to dependants in 2025-26, representing about 11% of the caseload, with £700,000 paid out to dependants. Going forward, the great news is that dependants under both schemes will benefit from equal payments to the sufferer. That is probably most of the points, but as I said, if there is anything else, I will check the record and write to noble Lords. I commend these amendments to both schemes to the Committee and ask approval to implement them. I beg to move.

More from Baroness Sherlock (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.